- Research works
- 58 ▲ 64% vs 2013–17
- Citations
- 5.3k 91.9 per fractional work
- Top-10% rate
- 41.8% record average 16.5%
- Open access
- 73% world 28%
Not ranked overall: Vir Biotechnology (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.8×. Every wedge is a field page.
- Immunology and Microbiology 8.8×
- Dentistry 7.4×
- Medicine 3.1×
- Biochemistry, Genetics and Molecular Biology 2.8×
- Veterinary 2.5×
- Pharmacology, Toxicology and Pharmaceutics 1.4×
- Nursing 1.1×
- Agricultural and Biological Sciences 0.7×
- Mathematics 0.6×
- Health Professions 0.5×
- Psychology 0.4×
- Environmental Science 0.2×
- Earth and Planetary Sciences 0.2×
- Engineering 0.2×
- Materials Science 0.1×
- Computer Science 0.0×
- Social Sciences 0.0×
Who are the top researchers at Vir Biotechnology (Switzerland)?
Ranked on the composite score, Davide Corti and Fabio Benigni lead among researchers whose main affiliation is Vir Biotechnology (Switzerland).
- 1 Davide Corti Switzerland · #34,955 worldwide 816 citations · 36 works
- 2 Fabio Benigni Switzerland · #196,009 worldwide 176 citations · 32 works
Which keywords describe research at Vir Biotechnology (Switzerland)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Vaccine, Pathogenesis, Immunity, Pandemic, Immune Response, Vaccine Development and SARS-CoV-2.
- Epitope Prediction
- Natural Killer Cells
- Human Metapneumovirus
- Bone Regeneration
- Rotavirus
- Influenza
- Tumor Antigen
- Fc Receptors
- Cancer Immunotherapy
- Innate Immunity
- Virus
- Antibodies
- antibody
- Inflammation
- Viral Transmission
- ACE2 Receptor
- SARS-CoV-2
- Immune Response
- Immunity
- Vaccine
- Epidemiology
- Pathogenesis
- Pandemic
- Vaccine Development
- Coronavirus
- Antigen Presentation
- Glycosylation
- Mutation
- spike protein
- Infection
- Antiviral Therapy
- Genomics
- Dendritic Cells
- Therapeutic Antibodies
- H1N1
- Norovirus
- Biomaterials
- Disease Burden
- NK Cell Recognition
- Respiratory Syncytial Virus
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology15▲ 6.7×35 topics
- Vaccine9▲ 38×9 topics
- Pathogenesis7▲ 23×14 topics
- Immunity7▲ 35×8 topics
- Pandemic6▲ 24×4 topics
- Immune Response6▲ 18×11 topics
- Vaccine Development6▲ 32×8 topics
- SARS-CoV-25▲ 59×5 topics
- Coronavirus4▲ 64×2 topics
- ACE2 Receptor4▲ 62×2 topics
- Antigen Presentation4▲ 65×2 topics
- Viral Transmission3▲ 61×3 topics
- Glycosylation3▲ 26×3 topics
- Inflammation3▲ 2.4×15 topics
- Mutation3▲ 36×2 topics
- antibody3▲ 125×1 topic
- spike protein3▲ 125×1 topic
- Antibodies3▲ 59×2 topics
- Infection3▲ 19×3 topics
- Virus3▲ 42×3 topics
- Antiviral Therapy3▲ 29×3 topics
- Innate Immunity3▲ 13×4 topics
- Genomics2▲ 12×2 topics
- Cancer Immunotherapy2▲ 28×2 topics
- Dendritic Cells2▲ 31×1 topic
- Fc Receptors2▲ 37×1 topic
- Therapeutic Antibodies2▲ 28×1 topic
- Tumor Antigen2▲ 44×1 topic
- H1N12▲ 98×1 topic
- Influenza2▲ 74×1 topic
- Norovirus2▲ 58×1 topic
- Rotavirus2▲ 58×1 topic
- Biomaterials2▲ 16×4 topics
- Bone Regeneration2▲ 30×2 topics
- Disease Burden2▲ 40×2 topics
- Human Metapneumovirus2▲ 67×1 topic
- NK Cell Recognition2▲ 32×1 topic
- Natural Killer Cells2▲ 32×1 topic
- Respiratory Syncytial Virus2▲ 67×1 topic
- Epitope Prediction2▲ 154×1 topic
Which research topics does Vir Biotechnology (Switzerland) publish most on?
By volume in 2022–2025: SARS-CoV-2 and COVID-19 Research, Viral gastroenteritis research and epidemiology, Animal Virus Infections Studies and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 1 works
- 2 Viral gastroenteritis research and epidemiology Infectious Diseases 1 works
- 3 Animal Virus Infections Studies Animal Science and Zoology 0 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 5 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
- 6 Dental Implant Techniques and Outcomes Oral Surgery 0 works
- 7 COVID-19 Clinical Research Studies Infectious Diseases 0 works
- 8 Respiratory viral infections research Epidemiology 0 works
- 9 Hepatitis B Virus Studies Epidemiology 0 works
- 10 Medical and Biological Sciences Anatomy 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Vir Biotechnology (Switzerland)'s research output changed?
Output in 2018–2022 was 64% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Bellinzona
- Institute of Oncology Research
- Ente Ospedaliero Cantonale
- Ospedale San Giovanni Bellinzona
- Ospedale Regionale di Bellinzona e Valli
- Repubblica e Cantone Ticino
- Federal Criminal Court
- Scuola Cantonale di Commercio Bellinzona
- International Extranodal Lymphoma Study Group
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.